Given its role in reducing blood sugar levels, it should come as no surprise that IGF1-LR3 reduces insulin levels as well as the need for exogenous insulin in diabetes
Holding a step longer is always better than pushing through
The authors reported that maximal brain GSH concentrations were measured ~90110 min after the start of the infusion, and had not returned to baseline levels by 120 min after the start of the infusion
For the complete clinical framework on how we start first-time peptide patients, including the body composition workup that drives protocol selection, see our complete medical clinic guide to how Perfect B starts a first-time peptide patient with an Inbody scan and a 12-week protocol
The secondary endpoints include achievement of 20% weight reduction, relative change in body weight, change in waist circumference, change in HbA1c, change in systolic blood pressure, change in the quality of life (IWQOL-Lite-CT), and change in short-form physical functioning score (SF-36v2)